BUILD THERAPEUTICS ApS: Financial statements 2017
CVR: 35400060
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
BUILD THERAPEUTICS ApS (CVR 35400060) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 0 and a net result of DKK -2,511 compared with DKK -2,511 the year before. Equity in the 2017 report amounted to DKK 64,445. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -2,511
- Equity
- DKK 64,445
- Total Assets
- DKK 64,445
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 0 | 0 | -3 t. | 64 t. | - |
| 2016 | 0 | 0 | -3 t. | 64 t. | - |
| 2015 | 0 | -495 | -4 t. | 67 t. | - |
| 2014 | 0 | -11 t. | -11 t. | 69 t. | - |
Official annual report
Keep an eye on BUILD THERAPEUTICS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of December 28, 2017, Søren Nyboe Jakobsen has stepped down as chairman of BUILD THERAPEUTICS ApS.
As of December 28, 2017, Søren Nyboe Jakobsen has stepped down as suppleant of BUILD THERAPEUTICS ApS.
As of December 28, 2017, Mikkel Dybro Lundorf has stepped down as vice chairman of BUILD THERAPEUTICS ApS.
As of December 28, 2017, Mikkel Dybro Lundorf has stepped down as adm. dir of BUILD THERAPEUTICS ApS.
BUILD THERAPEUTICS ApS was dissolved on December 28, 2017.
About BUILD THERAPEUTICS ApS
BUILD THERAPEUTICS ApS was a Danish company of the type Anpartsselskab based in Roskilde, founded in 2013. The company has been dissolved on 28 December 2017. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. In 2017, the company reported a gross profit of DKK 0 and a net result of DKK -2,511 compared with DKK -2,511 the year before. Equity in the 2017 report amounted to DKK 64,445.